Ubrig B, Böhme M, Merklinghaus A, Wagenlehner F
Klinik für Urologie, , Augusta-Kranken-Anstalt gGmbH, Bergstr. 26, 44791, Bochum, Deutschland.
Gemeinschaftspraxis für Urologie, Bochum-Wattenscheid, Bochum, Deutschland.
Urologe A. 2017 Jun;56(6):773-778. doi: 10.1007/s00120-017-0401-9.
Published studies on community-acquired urinary tract infections (UTI) often do not link microbiological findings with clinical risk factors and patient data.
We retrospectively correlated clinical findings of all patients with UTI of a urological outpatient clinic with the respective microbiological analysis of their urine samples over 2 periods of time: (A: 2005-2006 and B: 2011-2012). Patients were stratified to the following risk groups: uncomplicated cystitis, diabetes mellitus type 2, nursing home resident, prostatitis/epidydimitis, permanent catheter.
The incidence of Escherichia coli (p < 0.001) and proteus (p < 0.001) significantly decreased from period A to B, while enterococci (p = 0.003) and staphylococci (p < 0.001) significantly increased. Antibiotic sensitivity to fosfomycin (p < 0.001), doxycycline (p < 0.001), nitrofurantoin (p < 0.001), and nitroxoline increased (p < 0. 001) and sensitivity to amoxicillin (p < 0.001) and gentamicin decreased (p < 0.001). Patients with a permanent catheter had significantly poorer sensitivity rates (50% and less) for almost all antibiotics tested compared to the overall group. The risk of a UTI with 3MRGN or MRSA bacteria was significantly higher for catheter carriers and nursing home residents.
Empiric antibiotic first-line therapy with nitrofurantoin and fosfomycin for uncomplicated community acquired UTIs are well indicated in conformity with guidelines. The accumulation of multiresistant pathogens in patients with a permanent bladder catheter requires restrictive use of any permanent catheter drainage.
已发表的关于社区获得性尿路感染(UTI)的研究通常未将微生物学结果与临床危险因素及患者数据联系起来。
我们回顾性地将一家泌尿外科门诊所有UTI患者的临床结果与其尿液样本在两个时间段(A:2005 - 2006年和B:2011 - 2012年)各自的微生物学分析进行关联。患者被分为以下风险组:单纯性膀胱炎、2型糖尿病、养老院居民、前列腺炎/附睾炎、长期留置导尿管。
从A期到B期,大肠杆菌(p < 0.001)和变形杆菌(p < 0.001)的发生率显著下降,而肠球菌(p = 0.003)和葡萄球菌(p < 0.001)显著增加。对磷霉素(p < 0.001)、多西环素(p < 0.001)、呋喃妥因(p < 0.001)和硝羟喹啉的抗生素敏感性增加(p < 0.001),对阿莫西林(p < 0.001)和庆大霉素的敏感性降低(p < 0.001)。与总体组相比,长期留置导尿管的患者对几乎所有测试抗生素的敏感率明显更低(50%及以下)。导尿管携带者和养老院居民感染产超广谱β - 内酰胺酶(3MRGN)或耐甲氧西林金黄色葡萄球菌(MRSA)细菌导致UTI的风险显著更高。
根据指南,对于单纯性社区获得性UTI,使用呋喃妥因和磷霉素进行经验性抗生素一线治疗是合理的。长期膀胱导尿管患者中多重耐药病原体的积累需要严格限制任何长期导尿管引流的使用。